Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis. (Q44262171)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis. |
scientific article |
Statements
Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis (English)
Joseph Jorizzo
Daniel Stewart
Alicia Bucko
Steven A Davis
Paul Espy
Peter Hino
David Rodriguez
Ronald Savin
Dow Stough
Katharine Furst
Margaret Connolly
Sharon Levy
1 December 2002